Regulatory note: All three peptides are unapproved research chemicals and not FDA-approved for human use
BPC 157 protocols vary based on injury type, route of administration, formulation, and treatment goal
Standard Research Protocol Dose: 300 mcg per day subcutaneous injection Timing: Morning, fasted state (at least 30 minutes before food or exercise for maximal absorption) Cycle length: Typically 8 to 12 weeks on, followed by a 4-week rest period Reconstitution: Standard BAC water reconstitution
Every batch of BPC-157 undergoes rigorous HPLC-MS quality testing to verify purity, identity, and reproducibility giving researchers the confidence required for accurate and controlled laboratory experiments
Bacteriostatic Water$13 Injection Syringes$17 Alcohol Pads$9 Reconstitution Syringes$5 Syringe Tips (Vial Vent)$4 About AOD-9604 AOD9604 is a synthetic peptide derived from a modified fragment of human growth hormone (HGH) that targets fat metabolism
That documentation supports 90460 and the higher reimbursement that comes with it